Newsletter | June 25, 2024

06.25.24 -- Should You Rethink Novel Drug Production And Compliance Timelines?

SPONSOR

Proactive Strategies To Evaluate And Mitigate Clinical Supply Risk

Successful clinical trials are crucial for advancing a novel therapeutic to market and maintaining a competitive edge. Clinical trials face risks such as supply shortages which can cause costly delays and impact the safety and well-being of the patients involved in the trial. Learn about strategies that can help build an understanding of risk assessment when developing a clinical supply plan with this on demand webinar.

FEATURED EDITORIAL

Have We Got Novel Drug Production And Compliance Timelines All Wrong?

Drug developers might want to consider longer-term approaches to meeting manufacturing and regulatory requirements.

INDUSTRY INSIGHTS

Optimizing Autologous Cell Therapy Clinical Trials

Delve into four articles regarding dissecting the critical resources, processes, and key stakeholders essential for the successful completion of an ACT clinical trial.

Key Considerations For Selecting Flexible Fillers

Flexible fillers benefit drug developers looking for life cycle management of their drug products. Explore key considerations for selecting flexible fill/finish manufacturing technologies.

RTSM Manages Clinical IP Dispensation In Schizophrenia Study

Challenged by the dispensation of an investigational product (IP) across diverse patient subgroups, see what solution this pharma was able to utilize to ensure optimal distribution and minimize wastage.

Optimizing Storage & Distribution In An Era Of Clinical Trial Transformation

Explore the rapidly evolving complexities of clinical storage and distribution and how customized and patient-centric solutions have never been more paramount to support the healthcare of tomorrow.

SOLUTIONS

Commercial Drug Sourcing For Clinical Trials

International Supply Chain Management